Bernstein Liebhard LLP Reports On Status Of Federal Merck Fosamax Litigation

Bernstein Liebhard LLP reports on a new discovery order issued in the federal Merck Fosamax litigation, establishing protocols for the production of documents related to Fosamax femur fractures. New York, New York (PRWEB) June 01, 2012 Bernstein Liebhard LLP, a nationwide law firm representing clients who sustained Fosamax femur fractures as a result of taking the widely prescribed osteoporotic drug, reports that a new Case Management Order was recently issued in In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) (MDL No. 2243 Civ. No. 08-08 (JAP-LHG).* The Order,
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories